Award recordCONTRACT

NEW YORK BLOOD CENTER, INC

PIID 36C24418C0014· VHA· 244-NETWORK CONTRACT OFFICE 4 (36C244)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $459,870 net obligations· UEI FM98STHJNB99· DE

Description

BLOOD&BLOOD PRODUCTS

First action · last action
2017-11-01 · 2023-08-09
Transactions
14
First transaction's obligation
$215,431
Base + all options value (sum of deltas)
$1,353,547
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 14 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$610,979$0Base award · 2017-11-01 · this action $215,431 · running total $215,431Modification P00001 · 2018-11-01 · this action $127,993 · running total $343,424Modification P00002 · 2019-04-24 · this action -$140,516 · running total $202,909Modification P00003 · 2019-10-23 · this action $130,351 · running total $333,260Modification P00005 · 2020-03-19 · this action -$41,231 · running total $292,029Modification P00006 · 2020-04-30 · this action $2,822 · running total $294,851Modification P00004 · 2020-08-19 · this action $0 · running total $294,851Modification P00008 · 2020-10-21 · this action $0 · running total $294,851Modification P00007 · 2020-10-22 · this action $135,773 · running total $430,624Modification P00009 · 2021-04-19 · this action -$29,930 · running total $400,695Modification P00010 · 2021-09-20 · this action $35,923 · running total $436,618Modification P00011 · 2021-10-05 · this action $174,361 · running total $610,979Modification P00012 · 2023-05-25 · this action -$58,824 · running total $552,155Modification P00013 · 2023-08-09 · this action -$92,285 · running total $459,870
  • Base2017-11-01+$215,431= $215,431
  • Mod P000012018-11-01+$127,993= $343,424
  • Mod P000022019-04-24-$140,516= $202,909
  • Mod P000032019-10-23+$130,351= $333,260
  • Mod P000052020-03-19-$41,231= $292,029
  • Mod P000062020-04-30+$2,822= $294,851
  • Mod P000042020-08-19+$0= $294,851
  • Mod P000082020-10-21+$0= $294,851
  • Mod P000072020-10-22+$135,773= $430,624
  • Mod P000092021-04-19-$29,930= $400,695
  • Mod P000102021-09-20+$35,923= $436,618
  • Mod P000112021-10-05+$174,361= $610,979
  • Mod P000122023-05-25-$58,824= $552,155
  • Mod P000132023-08-09-$92,285= $459,870
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-11-01+$215,431$215,431BLOOD&BLOOD PRODUCTS
Mod P00001· FUNDING ONLY ACTION2018-11-01+$127,993$343,424BLOOD&BLOOD PRODUCTS
Mod P00002· FUNDING ONLY ACTION2019-04-24−$140,516$202,909BLOOD&BLOOD PRODUCTS
Mod P00003· EXERCISE AN OPTION2019-10-23+$130,351$333,260BLOOD&BLOOD PRODUCTS
Mod P00005· FUNDING ONLY ACTION2020-03-19−$41,231$292,029BLOOD&BLOOD PRODUCTS
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-04-30+$2,822$294,851BLOOD&BLOOD PRODUCTS
Mod P00004· ENTITY ADDRESS CHANGE2020-08-19+$0$294,851BLOOD&BLOOD PRODUCTS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-10-21+$0$294,851BLOOD&BLOOD PRODUCTS
Mod P00007· EXERCISE AN OPTION2020-10-22+$135,773$430,624BLOOD&BLOOD PRODUCTS
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-04-19−$29,930$400,695BLOOD&BLOOD PRODUCTS
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-09-20+$35,923$436,618BLOOD&BLOOD PRODUCTS
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-10-05+$174,361$610,979BLOOD&BLOOD PRODUCTS
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-05-25−$58,824$552,155BLOOD&BLOOD PRODUCTS
Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-08-09−$92,285$459,870BLOOD&BLOOD PRODUCTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FM98STHJNB99)

AwardOffice · PSC / listingNet obligationsFY
36C24126N0022241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$230,000FY2026
36C24125N0039241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$138,497FY2025
36C24124A0002241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C24124N0026241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$120,473FY2024
36C24423P0023244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$440,255FY2023
VA24417C0242244-NETWORK CONTRACT OFFICE 4 (36C244) · Q508 · MEDICAL- HEMATOLOGY$35,418FY2017

Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24426D0097CARDINAL HEALTH 414, LLC244-NETWORK CONTRACT OFFICE 4 (36C244)$0FY2026
36C24426N0938CARDINAL HEALTH 414, LLC244-NETWORK CONTRACT OFFICE 4 (36C244)$650,641FY2026
36C24426N0948ERA HEALTH LLC244-NETWORK CONTRACT OFFICE 4 (36C244)$29,590FY2026
36C24426P0339NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC244-NETWORK CONTRACT OFFICE 4 (36C244)$126,204FY2026
36C24426N0663LUMINEX CORP244-NETWORK CONTRACT OFFICE 4 (36C244)$121,316FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24418C0014_3600_-NONE-_-NONE- · retrieved 2026-09-26.